Semaglutide/NAD+ injection solution is a compounded medication prescribed under the guidance of a healthcare professional. Semaglutide/NAD+ injection solution is a combination of Semaglutide and Nicotinamide Adenine Dinucleotide (NAD+). This combination is formulated for combined appetite reduction, cellular energy production, and metabolism support.
Active - Semaglutide, Nicotinamide adenine dinucleotide / Inactive - Mannitol, Benzyl alcohol, Sterile water for injection
Semaglutide/NAD+ injection solution is specially formulated for individuals requiring metabolic support. It combines a GLP-1 receptor agonist with a naturally-occuring coenzyme to support overall appetite reduction, metabolism support, and energy production. Semaglutide may reduce cravings and support healthy weight management under the guidance of your healthcare provider. NAD+ plays key roles in mitochondrial activity, metabolism function, and energy production at the cellular level. Together, these ingredients may help enhance weight management efforts, increase energy levels, improve focus, and support overall well-being.
Use of Semaglutide/NAD+ injection solution has been shown to improve: metabolic disorders / energy depletion and fatigue / cardiovascular disease / chronic age-related diseases
Benefits of Semaglutide/NAD+ may include: increased energy levels / enhanced metabolic function / improved focus and cognitive function
Injection site reaction: mild, temporary pain, itching, or redness at the injection site. To mitigate these effects, ensure to follow the administration instructions provided with your prescription. / Less common side effects: flushing, headache, mild nausea, upset stomach, and other gastrointestinal effects can happen. / Rare side effects: severe itching, skin rash, and other effects associated with an allergic reaction can occur.
Before each use, ensure to read and follow the medication information provided with your prescription. Semaglutide/NAD+ can be administered as an intramuscular injection or subcutaneous injection. If you are prescribed Semaglutide/NAD+ as an intramuscular or subcutaneous injection, see administration instructions here.
Semaglutide/NAD+ injectable solution should be stored at refrigerated temperatures of 36F to 46F (or 2C to 8C). Store this medication away from light. Keep medications out of reach of children and pets. Discard this medication after 28 days of first use or according to the beyond-use date, whichever date comes first. Before each use, ensure to read and follow the medication information provided with your prescription.
When disposing of unused medication or expired vials, do not flush or pour down the drain. Follow local guidelines on medication disposal. If the Semaglutide/NAD+ vial is empty, discard with regular glass waste. For broken vials and needles, discard into a puncture-proof, red FDA-cleared sharps container to prevent needle-stick injuries.
If you choose to have your prescription delivered to your door by either our local delivery agent or one of our shipping partners, your medication will be monitored throughout the shipping process. Our refrigerated medication packages include a safety monitoring device and monitoring notification. See here for information regarding shipped medication safety monitoring.
Semaglutide/NAD+ injectable solution is dispensed in various volumes. Your vial contains the amount of medication stated on the label. The glass container is designed to hold different fill volumes, which may make your vial appear less full. This helps ensure proper storage, handling, and safe withdrawal of your dose. Your medication vial has undergone rigorous testing to ensure the safety, accuracy, and potency of the medication it contains. The exact amount of medication inside has been carefully measured and formulated to meet your specific needs.
Semaglutide/NAD+ is a compounded medication that is prescribed under the guidance of a healthcare professional. Patients and their prescribers should work together to determine whether prescription Semaglutide/NAD+ is appropriate for them prior to initiating Semaglutide/NAD+ therapy. Medication regimens should be evaluated as Semaglutide/NAD+ may interact with or alter the efficacy of certain medications.
Disclaimer: This information is for educational purposes only. This compounded product has not been reviewed, approved, or evaluated by the Food and Drug Administration for safety and effectiveness. This product is not intended to diagnose, treat, cure, or prevent any disease. No claims are made regarding treatment, cure, or prevention of any disease or condition. This information is a summary. It may not cover all possible drug information about this product. For complete product information, refer to the manufacturer’s prescribing information and labeling. Call your doctor for medical advice and/or about side effects.
Certifications, accreditations, and professional affliations that reflect our commitment to clinical excellence.
